Insider Transactions in Q2 2024 at Inspire Medical Systems, Inc. (INSP)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 31
2024
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Bona fide gift
|
Indirect |
3,000
-2.59%
|
-
|
|
May 29
2024
|
Charisse Y Sparks Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
64
-1.73%
|
-
|
|
May 10
2024
|
Shawn Mc Cormick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+13.96%
|
$0
$0.94 P/Share
|
|
May 02
2024
|
Cynthia Burks Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+34.08%
|
-
|
|
May 02
2024
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+15.12%
|
-
|
|
May 02
2024
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+3.41%
|
-
|
|
May 02
2024
|
Dana G Mead Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+3.24%
|
-
|
|
May 02
2024
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+25.41%
|
-
|
|
May 02
2024
|
Myriam Curet Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+25.43%
|
-
|
|
May 02
2024
|
Shawn Mc Cormick Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+5.26%
|
-
|
|
May 02
2024
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+23.69%
|
-
|
|
Apr 29
2024
|
Marilyn C Nelson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,175
+3.19%
|
$282,000
$240.68 P/Share
|
|
Apr 17
2024
|
Richard Buchholz Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
500
+8.47%
|
-
|
|
Apr 17
2024
|
Richard Buchholz Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
500
-1.77%
|
-
|
|
Apr 17
2024
|
Richard Buchholz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-34.67%
|
$3,450,000
$230.03 P/Share
|
|
Apr 12
2024
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
70
+4.22%
|
$16,170
$231.74 P/Share
|
|
Apr 12
2024
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
62
+0.32%
|
$14,322
$231.74 P/Share
|
|
Apr 12
2024
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
70
+2.07%
|
$16,170
$231.74 P/Share
|
|
Apr 12
2024
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
107
+0.31%
|
$24,717
$231.74 P/Share
|
|
Apr 12
2024
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
56
+3.88%
|
$12,936
$231.74 P/Share
|
|
Apr 01
2024
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Open market or private sale
|
Indirect |
40,000
-5.15%
|
$8,280,000
$207.6 P/Share
|
|
Apr 01
2024
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
32
-0.29%
|
$6,816
$213.99 P/Share
|
|
Apr 01
2024
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
296
+2.64%
|
$4,736
$16.0 P/Share
|
|
Apr 01
2024
|
Marilyn C Nelson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,273
+8.7%
|
$52,368
$16.0 P/Share
|